{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:33:45Z","timestamp":1785447225410,"version":"3.56.0"},"reference-count":98,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chromosome 13q deletion [del(13q)], harboring the miR-15a\/16-1 cluster, is one of the most common genetic alterations in mature B-cell malignancies, which originate from germinal center (GC) and post-GC B cells. Moreover, miR-15a\/16 expression is frequently reduced in lymphoma and multiple myeloma (MM) cells without del(13q), suggesting important tumor-suppressor activity. However, the role of miR-15a\/16-1 in B-cell activation and initiation of mature B-cell neoplasms remains to be determined. We show that conditional deletion of the miR-15a\/16-1 cluster in murine GC B cells induces moderate but widespread molecular and functional changes including an increased number of GC B cells, percentage of dark zone B cells, and maturation into plasma cells. With time, this leads to development of mature B-cell neoplasms resembling human extramedullary plasmacytoma (EP) as well as follicular and diffuse large B-cell lymphomas. The indolent nature and lack of bone marrow involvement of EP in our murine model resembles human primary EP rather than MM that has progressed to extramedullary disease. We corroborate human primary EP having low levels of miR-15a\/16 expression, with del(13q) being the most common genetic loss. Additionally, we show that, although the mutational profile of human EP is similar to MM, there are some exceptions such as the low frequency of hyperdiploidy in EP, which could account for different disease presentation. Taken together, our studies highlight the significant role of the miR-15a\/16-1 cluster in the regulation of the GC reaction and its fundamental context-dependent tumor-suppression function in plasma cell and B-cell malignancies.<\/jats:p>","DOI":"10.1182\/blood.2020009088","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T18:16:32Z","timestamp":1616436992000},"page":"1905-1919","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["<i>miR-15a\/16-1<\/i> deletion in activated B cells promotes plasma cell and mature B-cell neoplasms"],"prefix":"10.1182","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-8517","authenticated-orcid":false,"given":"Tomasz","family":"Sewastianik","sequence":"first","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9246-3392","authenticated-orcid":false,"given":"Juerg R.","family":"Straubhaar","sequence":"additional","affiliation":[{"name":"FAS Informatics, Harvard University, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet K.","family":"Samur","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"},{"name":"Department of Data Sciences, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Adler","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Tanton","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Shanmugam","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Nadeem","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Dennis","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-6226","authenticated-orcid":false,"given":"Vinodh","family":"Pillai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-9851","authenticated-orcid":false,"given":"Daniel","family":"Brooks","sequence":"additional","affiliation":[{"name":"Center for Advanced Orthopedic Studies, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bouxsein","sequence":"additional","affiliation":[{"name":"Center for Advanced Orthopedic Studies, Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Dorfman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine S.","family":"Pinkus","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-3484","authenticated-orcid":false,"given":"Davide F.","family":"Robbiani","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology, Rockefeller University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-2003","authenticated-orcid":false,"given":"Bogdan","family":"Budnik","sequence":"additional","affiliation":[{"name":"Mass Spectrometry and Proteomics Resource Laboratory, FAS Division of Science, Harvard University, Cambridge, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jarolim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil C.","family":"Munshi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"},{"name":"Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and"},{"name":"Jerome Lipper Center for Multiple Myeloma Research, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben D.","family":"Carrasco","sequence":"additional","affiliation":[{"name":"Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Department of Pathology, Brigham & Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2021040815220630900_B1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"5","key":"2021040815220630900_B2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrg1328","article-title":"Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs","volume":"5","author":"Bartel","year":"2004","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2021040815220630900_B3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1261\/rna.051193.115","article-title":"Two decades of miRNA biology: lessons and challenges","volume":"21","author":"Lai","year":"2015","journal-title":"RNA"},{"issue":"7209","key":"2021040815220630900_B4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"issue":"7043","key":"2021040815220630900_B5","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"5","key":"2021040815220630900_B6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nri.2016.40","article-title":"MicroRNAs as regulatory elements in immune system logic [published correction appears in Nat Rev Immunol. 2016;16(5):400]","volume":"16","author":"Mehta","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2021040815220630900_B7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2021040815220630900_B8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2021040815220630900_B9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2008.03.015","article-title":"MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase","volume":"28","author":"Teng","year":"2008","journal-title":"Immunity"},{"issue":"13","key":"2021040815220630900_B10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1084\/jem.20121387","article-title":"BCL6 positively regulates AID and germinal center gene expression via repression of miR-155","volume":"209","author":"Basso","year":"2012","journal-title":"J Exp Med"},{"issue":"7","key":"2021040815220630900_B11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/intimm\/dxq042","article-title":"MicroRNA 125b inhibition of B cell differentiation in germinal centers","volume":"22","author":"Gururajan","year":"2010","journal-title":"Int Immunol"},{"issue":"22","key":"2021040815220630900_B12","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1073\/pnas.1322466111","article-title":"MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas","volume":"111","author":"Schneider","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2021040815220630900_B13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood-2013-12-543611","article-title":"miR-217 is an oncogene that enhances the germinal center reaction","volume":"124","author":"de Y\u00e9benes","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2021040815220630900_B14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2021040815220630900_B15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De Silva","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"2021040815220630900_B16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.1998.tb01446.x","article-title":"Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes","volume":"162","author":"Stevenson","year":"1998","journal-title":"Immunol Rev"},{"issue":"24","key":"2021040815220630900_B17","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"26","key":"2021040815220630900_B18","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"2021040815220630900_B19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V89.2.734","article-title":"Deletion of 13q14.3 and not 13q12 is the most common genetic abnormality detected in chronic lymphocytic leukemia cells","volume":"89","author":"Panayiotidis","year":"1997","journal-title":"Blood"},{"issue":"14","key":"2021040815220630900_B20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.onc.1201764","article-title":"Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma","volume":"16","author":"Stilgenbauer","year":"1998","journal-title":"Oncogene"},{"issue":"7","key":"2021040815220630900_B21","first-page":"589","article-title":"13q14 deletion in non-Hodgkin\u2019s lymphoma: correlation with clinicopathologic features","volume":"84","author":"Cuneo","year":"1999","journal-title":"Haematologica"},{"issue":"5","key":"2021040815220630900_B22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.leu.2401395","article-title":"Frequent chromosome arm 13q deletion in aggressive non-Hodgkin\u2019s lymphoma","volume":"13","author":"Wada","year":"1999","journal-title":"Leukemia"},{"issue":"4","key":"2021040815220630900_B23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","article-title":"High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"key":"2021040815220630900_B24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","article-title":"Pathogenesis of myeloma","volume":"6","author":"Anderson","year":"2011","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"2021040815220630900_B25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ejh.12688","article-title":"Cytogenetics in multiple myeloma patients progressing into extramedullary disease","volume":"97","author":"Besse","year":"2016","journal-title":"Eur J Haematol"},{"issue":"4","key":"2021040815220630900_B26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41408-019-0199-3","article-title":"Deciphering the chronology of copy number alterations in multiple myeloma","volume":"9","author":"Aktas Samur","year":"2019","journal-title":"Blood Cancer J"},{"issue":"26","key":"2021040815220630900_B27","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1182\/blood-2009-01-198408","article-title":"MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma","volume":"113","author":"Roccaro","year":"2009","journal-title":"Blood"},{"issue":"1","key":"2021040815220630900_B28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"2021040815220630900_B29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/0008-5472.BCD-19-0068","article-title":"Monosomic loss of MIR15A\/MIR16-1 is a driver of multiple myeloma proliferation and disease progression","volume":"1","author":"Chesi","year":"2020","journal-title":"Blood Cancer Discov"},{"issue":"6","key":"2021040815220630900_B30","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"issue":"10","key":"2021040815220630900_B31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"21","key":"2021040815220630900_B32","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2019000588","article-title":"Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells","volume":"3","author":"Sewastianik","year":"2019","journal-title":"Blood Adv"},{"key":"2021040815220630900_B33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol Syst Biol"},{"issue":"5","key":"2021040815220630900_B34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2006.03.028","article-title":"The PTEN and INK4A\/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans [published correction appears in Cancer Cell. 2006;10(2):171]","volume":"9","author":"Carrasco","year":"2006","journal-title":"Cancer Cell"},{"issue":"3","key":"2021040815220630900_B35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/leu.2009.274","article-title":"Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling","volume":"24","author":"Guti\u00e9rrez","year":"2010","journal-title":"Leukemia"},{"issue":"14","key":"2021040815220630900_B36","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"issue":"11","key":"2021040815220630900_B37","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1084\/jem.20120127","article-title":"Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory","volume":"209","author":"Kaji","year":"2012","journal-title":"J Exp Med"},{"issue":"11","key":"2021040815220630900_B38","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood-2012-03-415380","article-title":"Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas [published correction appears in Blood. 2015;126(10):1262]","volume":"120","author":"Victora","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2021040815220630900_B39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.cell.2009.04.040","article-title":"SnapShot: microRNAs in cancer","volume":"137","author":"Spizzo","year":"2009","journal-title":"Cell"},{"issue":"database issue","key":"2021040815220630900_B40","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkh023","article-title":"The microRNA Registry","volume":"32","author":"Griffiths-Jones","year":"2004","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2021040815220630900_B41","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.4049\/jimmunol.178.6.3593","article-title":"T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature\/transitional 1 B cells","volume":"178","author":"Ueda","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"2021040815220630900_B42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20061952","article-title":"Regulation of AID expression in the immune response","volume":"204","author":"Crouch","year":"2007","journal-title":"J Exp Med"},{"issue":"12","key":"2021040815220630900_B43","doi-asserted-by":"crossref","first-page":"e29141","DOI":"10.1371\/journal.pone.0029141","article-title":"Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"2021040815220630900_B44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/cdd.2009.69","article-title":"miR-15a and miR-16-1 in cancer: discovery, function and future perspectives","volume":"17","author":"Aqeilan","year":"2010","journal-title":"Cell Death Differ"},{"issue":"D1","key":"2021040815220630900_B45","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"27","key":"2021040815220630900_B46","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.1073\/pnas.0903854106","article-title":"BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma","volume":"106","author":"Saito","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2021040815220630900_B47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1745-7270.2008.00418.x","article-title":"How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes","volume":"40","author":"Guo","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"3","key":"2021040815220630900_B48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"issue":"1","key":"2021040815220630900_B49","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol Cell"},{"issue":"6","key":"2021040815220630900_B50","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2021040815220630900_B51","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.190.9.1263","article-title":"Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion","volume":"190","author":"Lee","year":"1999","journal-title":"J Exp Med"},{"issue":"12","key":"2021040815220630900_B52","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"2021040815220630900_B53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I- and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2021040815220630900_B54","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/sj.onc.1209775","article-title":"STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas","volume":"26","author":"Walker","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"2021040815220630900_B55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni1172","article-title":"STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression","volume":"6","author":"Scheeren","year":"2005","journal-title":"Nat Immunol"},{"issue":"5","key":"2021040815220630900_B56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.immuni.2017.04.009","article-title":"Metabolic regulation of the immune humoral response","volume":"46","author":"Boothby","year":"2017","journal-title":"Immunity"},{"issue":"2","key":"2021040815220630900_B57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"issue":"10","key":"2021040815220630900_B58","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.4049\/jimmunol.1601401","article-title":"Germinal center hypoxia potentiates immunoglobulin class switch recombination","volume":"197","author":"Abbott","year":"2016","journal-title":"J Immunol"},{"issue":"11","key":"2021040815220630900_B59","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/15384101.2017.1317408","article-title":"Hypoxia favors the generation of human plasma cells","volume":"16","author":"Schoenhals","year":"2017","journal-title":"Cell Cycle"},{"issue":"3","key":"2021040815220630900_B60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1084\/jem.191.3.475","article-title":"bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells","volume":"191","author":"Smith","year":"2000","journal-title":"J Exp Med"},{"issue":"1","key":"2021040815220630900_B61","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.1200301","article-title":"IL-2 requirement for human plasma cell generation: coupling differentiation and proliferation by enhancing MAPK-ERK signaling","volume":"189","author":"Le Gallou","year":"2012","journal-title":"J Immunol"},{"issue":"3","key":"2021040815220630900_B62","doi-asserted-by":"crossref","first-page":"e20191043","DOI":"10.1084\/jem.20191043","article-title":"Syk degradation restrains plasma cell formation and promotes zonal transitions in germinal centers","volume":"217","author":"Davidzohn","year":"2020","journal-title":"J Exp Med"},{"issue":"12","key":"2021040815220630900_B63","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1172\/JCI72415","article-title":"Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression","volume":"124","author":"Sungalee","year":"2014","journal-title":"J Clin Invest"},{"key":"2021040815220630900_B64","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"2","key":"2021040815220630900_B65","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"Chesi","year":"2008","journal-title":"Cancer Cell"},{"issue":"20","key":"2021040815220630900_B66","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMicm1714471","article-title":"Raindrop Skull","volume":"378","author":"Solis","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"2021040815220630900_B67","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"2021040815220630900_B68","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"issue":"3","key":"2021040815220630900_B69","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2011-05-355412","article-title":"The RNase III enzyme Dicer is essential for germinal center B-cell formation","volume":"119","author":"Xu","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2021040815220630900_B70","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","article-title":"Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage","volume":"132","author":"Koralov","year":"2008","journal-title":"Cell"},{"issue":"16","key":"2021040815220630900_B71","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1101\/gad.1565607","article-title":"A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway","volume":"21","author":"O\u2019Carroll","year":"2007","journal-title":"Genes Dev"},{"issue":"2","key":"2021040815220630900_B72","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/blood-2014-06-578864","article-title":"A microRNA involved in the germinal center reaction","volume":"124","author":"K\u00fcppers","year":"2014","journal-title":"Blood"},{"key":"2021040815220630900_B73","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.coi.2014.01.003","article-title":"MicroRNA regulation of the germinal center response","volume":"28","author":"Baumjohann","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"2021040815220630900_B74","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.coi.2011.02.001","article-title":"MicroRNA control of lymphocyte differentiation and function","volume":"23","author":"Belver","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"2021040815220630900_B75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fgene.2014.00178","article-title":"Progress and challenge of microRNA research in immunity","volume":"5","author":"Lee","year":"2014","journal-title":"Front Genet"},{"issue":"5","key":"2021040815220630900_B76","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20161533","article-title":"Differentiation of germinal center B cells into plasma cells is initiated by high-affinity antigen and completed by Tfh cells","volume":"214","author":"Kr\u00e4utler","year":"2017","journal-title":"J Exp Med"},{"key":"2021040815220630900_B77","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.3389\/fimmu.2018.03106","article-title":"Expression of the plasma cell transcriptional regulator Blimp-1 by dark zone germinal center B cells during periods of proliferation","volume":"9","author":"Radtke","year":"2019","journal-title":"Front Immunol"},{"issue":"18","key":"2021040815220630900_B78","doi-asserted-by":"crossref","first-page":"9014","DOI":"10.1073\/pnas.1902510116","article-title":"Single-cell whole-genome sequencing reveals the functional landscape of somatic mutations in B lymphocytes across the human lifespan","volume":"116","author":"Zhang","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2021040815220630900_B79","first-page":"512","article-title":"Immunity, cancer and aging: lessons from mouse models","volume":"2","author":"Myers","year":"2011","journal-title":"Aging Dis"},{"issue":"1","key":"2021040815220630900_B80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-017-0006-x","article-title":"The twilight of immunity: emerging concepts in aging of the immune system [published correction appears in Nat Immunol. 2018;19(10):1146]","volume":"19","author":"Nikolich-\u017dugich","year":"2018","journal-title":"Nat Immunol"},{"issue":"28","key":"2021040815220630900_B81","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.18632\/oncotarget.24614","article-title":"Mouse models of multiple myeloma: technologic platforms and perspectives","volume":"9","author":"Rossi","year":"2018","journal-title":"Oncotarget"},{"issue":"3","key":"2021040815220630900_B82","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1073\/pnas.022643999","article-title":"IL-6 transgenic mouse model for extraosseous plasmacytoma","volume":"99","author":"Kovalchuk","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2021040815220630900_B83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/j.1460-2075.1990.tb08187.x","article-title":"An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene","volume":"9","author":"Rosenbaum","year":"1990","journal-title":"EMBO J"},{"key":"2021040815220630900_B84","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2021040815220630900_B85","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.0.CO;2-M","article-title":"Conspiracy of silence among repeated transgenes","volume":"20","author":"Henikoff","year":"1998","journal-title":"BioEssays"},{"issue":"24","key":"2021040815220630900_B86","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1093\/nar\/24.24.4902","article-title":"Variegated expression of a globin transgene correlates with chromatin accessibility but not methylation status","volume":"24","author":"Garrick","year":"1996","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2021040815220630900_B87","doi-asserted-by":"crossref","first-page":"e1006780","DOI":"10.1371\/journal.pgen.1006780","article-title":"Genetic compensation: a phenomenon in search of mechanisms","volume":"13","author":"El-Brolosy","year":"2017","journal-title":"PLoS Genet"},{"issue":"2","key":"2021040815220630900_B88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0092-8674(03)01075-4","article-title":"Principles of tumor suppression","volume":"116","author":"Sherr","year":"2004","journal-title":"Cell"},{"issue":"17","key":"2021040815220630900_B89","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"2021040815220630900_B90","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nri2998","article-title":"Expanding TRAF function: TRAF3 as a tri-faced immune regulator","volume":"11","author":"H\u00e4cker","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"1-2","key":"2021040815220630900_B91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"1","key":"2021040815220630900_B92","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/bjh.12223","article-title":"Cytogenetics of extramedullary manifestations in multiple myeloma","volume":"161","author":"Billecke","year":"2013","journal-title":"Br J Haematol"},{"issue":"9","key":"2021040815220630900_B93","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.bmt.1705982","article-title":"Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome","volume":"41","author":"Minnema","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"2021040815220630900_B94","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/sj.bmt.1704713","article-title":"Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome","volume":"34","author":"Zeiser","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2021040815220630900_B95","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma [published correction appears in Blood. 2018;132(13):1461]","volume":"132","author":"Walker","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2021040815220630900_B96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","article-title":"Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel","volume":"11","author":"Caers","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"18","key":"2021040815220630900_B97","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2021040815220630900_B98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/14\/1905\/1804510\/bloodbld2020009088r1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/14\/1905\/1804510\/bloodbld2020009088r1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T21:13:29Z","timestamp":1617916409000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/14\/1905\/474950\/miR-15a-16-1-deletion-in-activated-B-cells"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":98,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,4,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020009088","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]}}}